4-Quinolone resistance mutations in the DNA gyrase of Escherichia coli clinical isolates identified by using the polymerase chain reaction - PubMed (original) (raw)

4-Quinolone resistance mutations in the DNA gyrase of Escherichia coli clinical isolates identified by using the polymerase chain reaction

M Oram et al. Antimicrob Agents Chemother. 1991 Feb.

Abstract

Seven nalidixic acid-resistant clinical isolates of Escherichia coli were shown to carry resistance mutations in their gyrase A proteins. Six had serine-83 to leucine or tryptophan changes; the seventh had an aspartate-87 to valine substitution. The frequent occurrence of a mutation at serine-83 implies a key role for this residue in quinolone action.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Proc Natl Acad Sci U S A. 1978 Apr;75(4):1773-7 - PubMed
    1. Proc Natl Acad Sci U S A. 1977 Nov;74(11):4772-6 - PubMed
    1. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463-7 - PubMed
    1. J Bacteriol. 1969 Jul;99(1):238-41 - PubMed
    1. J Bacteriol. 1965 Apr;89:1068-74 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources